Dongsheng Tu
Dongsheng Tu
Professor of Biostatistics, Queen's University at Kingston, Canada
Adresă de e-mail confirmată pe ctg.queensu.ca
Citat de
Citat de
Erlotinib in previously treated non–small-cell lung cancer
FA Shepherd, J Rodrigues Pereira, T Ciuleanu, EH Tan, V Hirsh, ...
New England journal of medicine 353 (2), 123-132, 2005
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
CS Karapetis, S Khambata-Ford, DJ Jonker, CJ O'Callaghan, D Tu, ...
New England Journal of Medicine 359 (17), 1757-1765, 2008
The jackknife and bootstrap
J Shao, D Tu
Springer Science & Business Media, 2012
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic, DJ Sargent, MJ Moore, SN Thibodeau, AJ French, ...
New England Journal of Medicine 349 (3), 247-257, 2003
Cetuximab for the treatment of colorectal cancer
DJ Jonker, CJ O'Callaghan, CS Karapetis, JR Zalcberg, D Tu, HJ Au, ...
New England Journal of Medicine 357 (20), 2040-2048, 2007
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer
PE Goss, JN Ingle, S Martino, NJ Robert, HB Muss, MJ Piccart, ...
New England Journal of Medicine 349 (19), 1793-1802, 2003
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA. 17
PE Goss, JN Ingle, S Martino, NJ Robert, HB Muss, MJ Piccart, ...
Journal of the National Cancer Institute 97 (17), 1262-1271, 2005
Morphine, gabapentin, or their combination for neuropathic pain
I Gilron, JM Bailey, D Tu, RR Holden, DF Weaver, RL Houlden
New England Journal of Medicine 352 (13), 1324-1334, 2005
Exemestane for breast-cancer prevention in postmenopausal women
PE Goss, JN Ingle, JE Alés-Martínez, AM Cheung, RT Chlebowski, ...
New England Journal of Medicine 364 (25), 2381-2391, 2011
Association of KRAS p. G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab
W De Roock, DJ Jonker, F Di Nicolantonio, A Sartore-Bianchi, D Tu, ...
Jama 304 (16), 1812-1820, 2010
Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women …
MN Levine, VH Bramwell, KI Pritchard, BD Norris, LE Shepherd, ...
Journal of Clinical oncology 16 (8), 2651-2658, 1998
HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy
KI Pritchard, LE Shepherd, FP O'Malley, IL Andrulis, D Tu, VH Bramwell, ...
New England Journal of Medicine 354 (20), 2103-2111, 2006
Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma
AM Davis, B O'Sullivan, R Turcotte, R Bell, C Catton, P Chabot, J Wunder, ...
Radiotherapy and oncology 75 (1), 48-53, 2005
Extending aromatase-inhibitor adjuvant therapy to 10 years
PE Goss, JN Ingle, KI Pritchard, NJ Robert, H Muss, J Gralow, K Gelmon, ...
New England Journal of Medicine 375 (3), 209-219, 2016
Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials.
E Mitry, AL Fields, H Bleiberg, R Labianca, G Portier, D Tu, D Nitti, V Torri, ...
Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix
R Pearcey, M Brundage, P Drouin, J Jeffrey, D Johnston, H Lukka, ...
Journal of Clinical Oncology 20 (4), 966-972, 2002
Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial
I Gilron, JM Bailey, D Tu, RR Holden, AC Jackson, RL Houlden
The Lancet 374 (9697), 1252-1261, 2009
Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN. 5 randomised trials): pooled trial results, systematic review, and meta …
The Lancet 373 (9658), 137-146, 2009
Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21
A Bezjak, D Tu, L Seymour, G Clark, A Trajkovic, M Zukin, J Ayoub, ...
J Clin Oncol 24 (24), 3831-3837, 2006
Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of …
MJ Moore, J Hamm, J Dancey, PD Eisenberg, M Dagenais, A Fields, ...
Journal of clinical oncology 21 (17), 3296-3302, 2003
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20